Physical Therapists in Emporia, KS Accepting Medicare

25 Physical Therapists found. Showing 21 - 25

Mrs. Dana Maureen Green, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1620 Wheeler St, Emporia, KS 66801 Phone: 620-342-3280

Mr. Dale Dean Barb, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1024 W 12th Ave, Emporia, KS 66801 Phone: 620-342-4100    Fax: 620-342-6423

Jacob Gould Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2812 W 12th Ave, Emporia, KS 66801 Phone: 620-208-7878    Fax: 620-208-7000

Mr. Greg Alan Bachman, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2812 W 12th Ave, Emporia, KS 66801 Phone: 620-208-7878    Fax: 620-208-7000

Mr. Jason Lyle Konrade, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2917 W Hwy 50, Emporia, KS 66801 Phone: 620-343-9900    Fax: 620-343-9904

News Archive

Face masks worn by TB patients could cut transmission rates to non-infected patients

Face masks worn by patients infected with tuberculosis (TB) may be able to significantly cut transmission rates to non-infected patients, according to a new study by researchers from the U.S. and South Africa. The study was conducted in a specialized airborne infections research facility in South Africa, which was designed to allow study of methods to control the spread of TB.

Hillenbrand enters definitive agreement to acquire Coperion

Hillenbrand, Inc. has entered into a definitive agreement to acquire privately held Coperion Capital, a portfolio company of Deutsche Beteiligungs AG, for an estimated purchase price of €408 million ($530 million at current exchange rates), which includes the assumption of an estimated €76 million of net debt and €100 million pension liability.

BonAlive Biomaterials, Olympus Biotech sign multi-year exclusive distribution agreement

BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices and an emerging leader in indications involving the treatment of chronically infected bone, and Olympus Biotech International Ltd, a wholly owned company of Olympus Corporation focused on minimally-invasive regenerative therapies in bone and soft tissues, today announced the signing of a multi-year exclusive distribution agreement.

A sneak peek of the current state and future use of artificial intelligence in pathology

Artificial intelligence can already scan images of the eye to assess patients for diabetic retinopathy, a leading cause of vision loss, and find evidence of strokes on brain CT scans.

Read more Medical News

› Verified 8 days ago

• 1
• 2(current)